Bradshaw Start free trial

Re-Aim Therapeutics Ltd

Active

Data to 4 Nov 2026, 01:07

Company number
15689618
Sector
Not in a live sector
SIC group
Life sciences and health
Region
South East (Oxford)
Incorporated
29 Apr 2024
SIC code
72110
Trading name
Not found
Website
Not found

Re-Aim Therapeutics Ltd has 2 priced rounds on record from share allotment filings at Companies House. The latest was allotted on 2 Oct 2025, raised £7.00m, and was filed on 7 Oct 2025. Data to 3 Nov 2026.

Companies with significant control: Syncona Portfolio Limited (25 to 50%). From the PSC register.

2

Priced rounds

Allotted Mar 2025 to Oct 2025

£7.35m

Cash raised in those rounds

Sum of sterling cash raised in each round, as filed

2 Oct 2025

Latest round allotted

Filed 7 Oct 2025

Jump to

Funding rounds

Priced equity rounds read from share allotment filings at Companies House, newest first.

Edit columns
Funding rounds for Re-Aim Therapeutics Ltd
Allotted First filed Cash raised Filing
2 Oct 2025to 3 Oct 2025Latest 7 Oct 2025 £7.00m Open filing
23 Mar 2025to 28 Mar 2025 25 Mar 2025 £348k Open filing
Price per share, post-money and step-ups for these 2 rounds are in the full company page.

Companies with significant control

Companies with significant control over Re-Aim Therapeutics Ltd, from the register of people with significant control. A company can have control without holding shares. Individuals are not shown on public pages.

Edit columns
Companies with significant control
Holder Notified Ceased Shares held
Syncona Portfolio Limited 3 Oct 2025 n/a 25 to 50%

From the PSC register.

Filings

The latest 5 capital filings other than share allotments (SH01), which are listed under Funding rounds. 4 share filings (SH01 and SH02) have been read for this company.

Edit columns
Latest capital filings
Date Filing Document
10 Oct 2025 Resolution Open at Companies House
10 Oct 2025 Memorandum and articles (MA) Open at Companies House
10 Oct 2025 Memorandum and articles (MA) Open at Companies House
1 Apr 2025 Resolution Open at Companies House
23 Mar 2025 Subdivision or consolidation of shares (SH02) Open at Companies House

Documents open at Companies House. Bradshaw does not store or re-host them.

About this page

This page shows public register data for Re-Aim Therapeutics Ltd. Figures come from filings at Companies House; Bradshaw links to each filing and does not host copies. To correct or object to data about you, use the data request form.

Last updated 3 Nov 2026